Significant breakthroughs have been realized in medical care in modern times. Prostate cancer screening process is a disease control method that detects the presence of the cancer in advance before the symptoms become present. The cancerous growth takes a long while to develop although in some cases it does not develop.
Tests are often carried out to view and tell the extent and presence of the prostate cancer. The first test to determine any abnormalities around the prostate glands and the presence of any lumps on the glands. This is referred to as the Digital-Rectal Exam carried out by a physician who introduces a lubricated finger with gloves to the rectum.
The prostate specific antigen test which measures the quantity of the antigens specific to prostate and are made by the prostate in the blood. The PSA levels in men are considered to be higher in men with cancerous growth present in them. It may also increased by other factors affecting the glands. Certain medical procedures and medications as well as age and race may also affect the PSA levels.
After the PSA based screening tests a patient may test positive for asymptomatic cancer which may or may not develop over time. This entirely depends on the patient.
The primary goal of cancer screening is to decrease the number of deaths caused by this disease. It would also reduce the development of the metastasizing disease. Men detected with cancerous growth are divided into three categories depending on how far the tumor has spread. Those who shall result in death despite speedy detection as well as treatment, those who survive in the absence of screening and those who eventually survive due to the early diagnosis and proper treatment. There's a smaller chance of survival even with the early diagnosis and treatment.
Negative psychological traumas such as constant agitation concerning cancer could affect the PSA test results. These results have uncertainty and are not a hundred percent reliable. The screening procedure may harm the patient and bring about certain effects such as pain, fever, bleeding, infections and urinary difficulties. The treatment procedures such as biopsies could also lead to the patient experiencing some of these effects and are thus advised to consult medical advice as soon as they occur.
PSA screening's long term effects have not been proven yet. Although studies carried out show that their efficiency in reducing the cancers mortality rates have not been successful so far and are minimal. Most men experience the effects of the screen detection and the treatment procedure too early and recurrent and thus are more prone to early deaths.
Men are constantly exposed to effects that are more than the benefits brought about by the screen tests and treatment procedures. Over treatment as a result of the screen tests and treatment processes cause the men to experience unexpectedly harmful effects that would interfere with the asymptomatic stage of the disease.
Doctors and patients need to assess the balance between the advantages and disadvantages of early detection through the screen tests and early treatment. They are meant to determine if it provides chances of preventing death which are low or if it aggregates the prostate cancer through the persistent harm caused by the treatment procedures.
Tests are often carried out to view and tell the extent and presence of the prostate cancer. The first test to determine any abnormalities around the prostate glands and the presence of any lumps on the glands. This is referred to as the Digital-Rectal Exam carried out by a physician who introduces a lubricated finger with gloves to the rectum.
The prostate specific antigen test which measures the quantity of the antigens specific to prostate and are made by the prostate in the blood. The PSA levels in men are considered to be higher in men with cancerous growth present in them. It may also increased by other factors affecting the glands. Certain medical procedures and medications as well as age and race may also affect the PSA levels.
After the PSA based screening tests a patient may test positive for asymptomatic cancer which may or may not develop over time. This entirely depends on the patient.
The primary goal of cancer screening is to decrease the number of deaths caused by this disease. It would also reduce the development of the metastasizing disease. Men detected with cancerous growth are divided into three categories depending on how far the tumor has spread. Those who shall result in death despite speedy detection as well as treatment, those who survive in the absence of screening and those who eventually survive due to the early diagnosis and proper treatment. There's a smaller chance of survival even with the early diagnosis and treatment.
Negative psychological traumas such as constant agitation concerning cancer could affect the PSA test results. These results have uncertainty and are not a hundred percent reliable. The screening procedure may harm the patient and bring about certain effects such as pain, fever, bleeding, infections and urinary difficulties. The treatment procedures such as biopsies could also lead to the patient experiencing some of these effects and are thus advised to consult medical advice as soon as they occur.
PSA screening's long term effects have not been proven yet. Although studies carried out show that their efficiency in reducing the cancers mortality rates have not been successful so far and are minimal. Most men experience the effects of the screen detection and the treatment procedure too early and recurrent and thus are more prone to early deaths.
Men are constantly exposed to effects that are more than the benefits brought about by the screen tests and treatment procedures. Over treatment as a result of the screen tests and treatment processes cause the men to experience unexpectedly harmful effects that would interfere with the asymptomatic stage of the disease.
Doctors and patients need to assess the balance between the advantages and disadvantages of early detection through the screen tests and early treatment. They are meant to determine if it provides chances of preventing death which are low or if it aggregates the prostate cancer through the persistent harm caused by the treatment procedures.
About the Author:
You can visit smart-surgery.com for more helpful information about Answers On Prostate Cancer Screening.
